Cyclin D1 (Phospho-T288) Polyclonal Antibody-BS64572

Cyclin D1 (Phospho-T288) Polyclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: BS64572-50, BS64572-100

Product: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Swiss-Prot: P24385

Host: Rabbit

Reactivity: Human, Mouse, Rat

Applications: WB

All Applications: WB:1:500~1:1000

Background: Considerable effort directed towards the identification of G1 cyclins has led to the isolation of cyclin D, cyclin C and cyclin E. Of these, cyclin D corresponds to a putative human oncogene, designated PRAD1, which maps at the site of the Bcl1 rearrangement in certain lymphomas and leukemias. Two additional human type D cyclins, as well as their mouse homologs, have been identified. Evidence has established that members of the cyclin D family function to regulate phosphorylation of the retinoblastoma gene product, thereby activating E2F transcription factors.

Purification and Purity: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: Cyclin D1 (Phospho-T288) polyclonal antibody detects endogenous levels of Cyclin D1 protein only when phosphorylated at Thr288.

Bioworld Molecular Weight: ~ 33 kDa

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Western Blot (WB) analysis of Cyclin D1 (Phospho-T288) polyclonal antibody at 1:500 dilution
Lane A: HCT116 whole cell lysate

Alternative Name: G1/S-specific cyclin-D1; B-cell lymphoma 1 protein; BCL-1; BCL-1 oncogene; PRAD1 oncogene; CCND1; BCL1; PRAD1

Immunogen: Synthetic phosphopeptide derived from human Cyclin D1 around the phosphorylation site of Threonine 288.

Conjugate: Unconjugated

Modification: Phosphorylation